What happened so far?
Emerging markets have been hit hard by the Covid-19 sell-off, suffering large outflows, more than in any crisis of the past 15 years*, and this despite not being as hard hit as developed countries with lower official death rates and less severe restrictions.
Policy support
In April, global markets enjoyed a stimulus-fuelled rally on evidence that the Covid-19 outbreak is getting contained. Emerging markets have also stabilised on growing evidence the pandemic’s impacts will be less severe, along with improving dollar liquidity averting a dollar squeeze/debt crisis so far.
Economic uncertainties persist
Although very early and difficult to assess and quantify the full impact of Covid-19, the second-order economic effects from lockdowns, shuttered tourist industries and weakened external and domestic demand are still a headwind for Emerging markets.
Big picture view
The current crisis is mostly reinforcing previous trends of slowing global growth, and dispersion of economic performance between countries. If liquidity injections, monetary and fiscal stimulus from advanced economies and a possible weaker dollar can provide further support to Emerging markets, medium-term outlook remains uncertain, therefore selectivity will remain key to navigate through this volatile and fragile environment.
Diverging conditions
A clear separation seems to be operating among Emerging countries:
The Chinese case
*Source: Carmignac, Bloomberg, Gavekal research, 07/05/2020
This is an advertising document. This article may not be reproduced, in whole or in part, without prior authorisation from the management company. It does not constitute a subscription offer, nor does it constitute investment advice. The information contained in this article may be partial information and may be modified without prior notice. Past performance is not necessarily indicative of future performance. Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. In the United Kingdom, this article was prepared by Carmignac Gestion and/or Carmignac Gestion Luxembourg and is being distributed in the UK by Carmignac Gestion Luxembourg UK Branch (Registered in England and Wales with number FC031103, CSSF agreement of 10/06/2013).